Navamedic ASA (N1A)

Overview

Navamedic ASA stands as a distinguished pharmaceutical company with its core operations in Northern Europe. Since its inception in 2002 and following its rebranding from Glucomed AS in 2004, this Oslo, Norway-based entity has been dedicated to developing, producing, marketing, and selling an array of pharmaceuticals and related products. With a business model that meticulously incorporates both prescription and non-prescription pharmaceuticals, medical devices, medical nutrition products, food supplements, and cosmetics, Navamedic ASA has effectively catered to a broad spectrum of healthcare needs. The company's extensive product portfolio is well-structured to address a wide range of therapeutic areas, ensuring a significant impact on healthcare service delivery and patient care in its operational territories.

Products and Services

Navamedic ASA's offerings are comprehensive, spanning across various healthcare segments:

• Medical Nutrition Products: These are aimed at supporting patients with metabolic disorders and nutritional needs. The range includes specialized formulas for conditions like phenylketonuria, homocystinuria, maple syrup urine disease, and several other inherited metabolic disorders. Additionally, products are available for managing glycogen storage diseases, renal diseases, fat metabolism issues, malnutrition, and supporting a ketogenic diet, highlighting the company's focus on addressing complex nutritional challenges.
• Consumer Health Products: Encompassing non-prescription drugs and healthcare products, this segment serves various common health concerns such as pain relief, cough and cold, gastrointestinal troubles, obesity, and women's health. These products are primarily distributed through pharmacies and drugstores, ensuring wide accessibility to the general public.
• Specialty Pharmaceutical Products: Navamedic ASA offers a specialized assortment of pharmaceutical products across different therapeutic areas like dermatology, wound care, urology, and obesity. This diversification underlines the company's commitment to addressing more specialized healthcare needs beyond its general product offerings.
• Branded Generics: The company also provides branded generic medications, focusing on areas such as cardiology and antibiotics. This division underlines an essential aspect of Navamedic's strategy, offering cost-effective alternatives to brand-name medications while ensuring high quality and efficacy.

Navamedic ASA prides itself on a robust distribution network that effectively reaches hospitals, patients, and pharmacies, underscoring its dedication to enhancing accessibility and convenience in healthcare product procurement. Through its diverse and comprehensive product lineup, the company plays a pivotal role in the healthcare ecosystem, providing solutions that aim to improve the quality of life for patients across Northern Europe.